LUNG

Pulmonx Corp. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website ulmonx.com
Employees(FY) 269
ISIN US7458481014

Performance

-4.26%

-12.97%

-13.99%

-17.28%

-13.99%

YTD

-56.02%

Profile

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.

Advanced Technical Analysis

Technical Analysis of LUNG 2025-02-03

The stock indicators present a mixed sentiment, with a bearish Moving Average Score of 10 and a Technical Score of 20, suggesting underlying weakness, while the Oscillators Score of 60 indicates a neutral to slightly bullish momentum. Overall, the combined scores reflect a cautious outlook, highlighting potential volatility and the need for care...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of LUNG

Stock Rank

Recent News & Updates

2024-04-02 04:05
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer(Globenewswire)
2024-03-15 05:00
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-02-29 10:35
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp(Yahoo Finance)
2024-02-25 19:00
Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial(Businesswire)
2024-02-23 06:20
Pulmonx Full Year 2023 Earnings: Beats Expectations(Simply Wall St.)
2024-02-22 09:55
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript(Insider Monkey)
2024-02-22 06:56
Q4 2023 Pulmonx Corp Earnings Call(Thomson Reuters StreetEvents)
2024-02-21 20:55
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-02-21 16:44
Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses(GuruFocus.com)
2024-02-21 16:06
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results(GlobeNewswire)
2024-02-21 16:05
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer(GlobeNewswire)
2024-02-21 03:06
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-02-21 03:05
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer(Globenewswire)
2024-02-17 00:08
Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG)(GuruFocus.com)
2024-02-13 13:08
PRIMECAP Management Bolsters Position in Pulmonx Corp(GuruFocus.com)
2024-02-07 16:05
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024(GlobeNewswire)
2024-02-07 03:05
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024(Globenewswire)
2023-12-22 23:19
Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)(GuruFocus.com)
2023-12-11 09:00
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors(GlobeNewswire)
2023-12-10 20:00
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors(globenewswire)
2023-11-17 13:08
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare(InvestorPlace)
2023-11-15 16:05
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference(GlobeNewswire)
2023-11-15 03:05
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference(globenewswire)
2023-10-31 16:05
Pulmonx to Participate at Upcoming Investor Conferences(GlobeNewswire)
2023-10-31 09:00
Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript(Insider Monkey)
2023-10-31 07:03
Q3 2023 Pulmonx Corp Earnings Call(Thomson Reuters StreetEvents)
2023-10-31 04:05
Pulmonx to Participate at Upcoming Investor Conferences(globenewswire)
2023-10-30 21:00
Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript(insidermonkey)
2023-10-30 18:30
Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates(Zacks)
2023-10-30 05:53
Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results(Yahoo Finance)

Page 2 of 6

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.